Bright Minds Biosciences Inc.
DRUG
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.78M | -6.38M | -2.42M | -789.60K | -2.06M |
| Total Depreciation and Amortization | 54.90K | 91.70K | 58.40K | 56.10K | 54.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.10M | 1.04M | -335.50K | -611.00K | 616.90K |
| Change in Net Operating Assets | 409.60K | -387.10K | -224.90K | -484.30K | 26.60K |
| Cash from Operations | -6.21M | -5.63M | -2.92M | -1.83M | -1.37M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -100.10K | -97.90K | -94.30K | -91.70K | -89.90K |
| Issuance of Common Stock | 86.03M | 49.82M | 49.81M | 49.56M | 900.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -360.20K | 2.51M | 2.51M | 2.51M | -- |
| Cash from Financing | 61.51M | 37.30M | 37.30M | 37.13M | 595.80K |
| Foreign Exchange rate Adjustments | 211.00K | 607.30K | 1.19M | 1.20M | 8.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 55.51M | 32.28M | 35.57M | 36.50M | -761.30K |